CN109259229A - Momordica grosvenori tablets and its preparation process - Google Patents
Momordica grosvenori tablets and its preparation process Download PDFInfo
- Publication number
- CN109259229A CN109259229A CN201811474320.5A CN201811474320A CN109259229A CN 109259229 A CN109259229 A CN 109259229A CN 201811474320 A CN201811474320 A CN 201811474320A CN 109259229 A CN109259229 A CN 109259229A
- Authority
- CN
- China
- Prior art keywords
- powder
- siraitia grosvenorii
- nattokinase
- soybean lecithin
- oatmeal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241001409321 Siraitia grosvenorii Species 0.000 title 1
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 44
- 239000000843 powder Substances 0.000 claims abstract description 34
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 20
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 20
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 20
- 235000012054 meals Nutrition 0.000 claims abstract description 18
- 235000013336 milk Nutrition 0.000 claims abstract description 18
- 239000008267 milk Substances 0.000 claims abstract description 18
- 210000004080 milk Anatomy 0.000 claims abstract description 18
- 229940086319 nattokinase Drugs 0.000 claims abstract description 18
- 108010073682 nattokinase Proteins 0.000 claims abstract description 18
- 241001529734 Ocimum Species 0.000 claims abstract description 16
- 235000010676 Ocimum basilicum Nutrition 0.000 claims abstract description 16
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 14
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 14
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000005303 weighing Methods 0.000 claims abstract description 10
- 235000020985 whole grains Nutrition 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 238000005469 granulation Methods 0.000 claims abstract description 7
- 230000003179 granulation Effects 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 239000011122 softwood Substances 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000006735 deficit Effects 0.000 abstract description 4
- 206010011224 Cough Diseases 0.000 abstract description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000007536 Thrombosis Diseases 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000001228 trophic effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000009286 beneficial effect Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000002537 thrombolytic effect Effects 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 231100000354 acute hepatitis Toxicity 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 230000003212 lipotrophic effect Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Momordica grosvenori tablets and its preparation process are made of Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed, soy meal and maltodextrin powder, and wherein each component quality proportioning is Siraitia grosvenorii 5.0%-10.0%；Nattokinase 0.01%-0.5%；Milk powder 5.0%-20.0%；Oatmeal 5.0%-20.0%；Soybean lecithin 5.0%-15.0%；Basil seed 5.0%-10.0%；Soy meal 5.0%-15.0%；Surplus is maltodextrin powder, and major ingredient is carried out weighing mixing, softening, granulation, dry whole grain, auxiliary material maltodextrin powder, last tabletting is added.The present invention is by compounding certain proportion milk powder, oatmeal, basil seed and soy meal with Siraitia grosvenorii, it not only can be with clearing heat and cooling blood, cough-relieving of promoting the production of body fluid, tender skin benefit face, moistening lung for removing phlegm, and the side effect of the Siraitia grosvenorii impairment of the spleen can be improved, Nattokinase can effectively reduce the formation of thrombus of heart blood vessel in being formulated at the same time, the solvable blood lipid of soybean lecithin, the trophic function for improving momordica grosvenori tablets has the advantages that simple process, full of nutrition and natural without side-effects.
Description
Technical field
The present invention relates to health care beverage technology fields, and in particular to a kind of momordica grosvenori tablets and its preparation process.
Background technique
Siraitia grosvenorii nutritive value is very high, contains a large amount of glucose, fructose, polysaccharide, protein, amino acid, flavonoids, dimension
Raw element C, enzyme, mineral element, there are also sweetener Lo Han Guo sweet tea glycosides, have sweet in flavor cool in nature, moistening lung to arrest cough, promote the production of body fluid to quench thirst and other effects.
In addition, Siraitia grosvenorii or a kind of high sugariness, natural sweetener low in calories, can be widely applied to food additives field, especially
Suitable for coronary heart disease, hypertension, diabetes and obese patients.But since Siraitia grosvenorii fresh fruit is not easy to maintain, peasant household is usually
It will be saved after the dry or further deep processing of the fresh fruit of picking.Current existing drying means includes medium and high temperature drying or freezing
It is dry, but general drying means does not consider drying temperature to effective component in Siraitia grosvenorii (such as Momordica grosvenori mogroside V)
It influences, so that the active constituent in Siraitia grosvenorii cannot be retained.
In recent years, more and more about the drink of Siraitia grosvenorii in the market, but kind mouthfeel and effect are single, are not able to satisfy people
To the diversified demand of Siraitia grosvenorii health care.
Summary of the invention
The present invention provides a kind of momordica grosvenori tablets and its preparation processes, to solve mouthfeel and effect list of the existing technology
One the problem of.
The technical solution adopted by the present invention to solve the technical problems is:
A kind of momordica grosvenori tablets, by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed, soy meal and wheat
Bud dextrine powder composition, wherein each component quality proportioning is Siraitia grosvenorii 5.0%-10.0%；Nattokinase 0.01%-0.5%；Milk powder
5.0%-20.0%；Oatmeal 5.0%-20.0%；Soybean lecithin 5.0%-15.0%；Basil seed 5.0%-10.0%；Soy meal 5.0%-
15.0%；Surplus is maltodextrin powder.
The preparation process of above-mentioned momordica grosvenori tablets is by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, orchid
Fragrant son and soy meal carry out weighing mixing, softening, granulation, dry whole grain, are added auxiliary material maltodextrin powder, last tabletting, specifically
Processing step is as follows:
(1) by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed and soy meal according to product formula
Proportion requirement carries out weighing weighing respectively；
(2) above-mentioned load weighted raw material is placed in mixing agitator and carries out mixing to uniformly for 30min；
(3) it is that be prepared into softwood spare for wetting agent stirring that suitable pure water, which is added, in material after mixing；
(4) softwood of above-mentioned preparation is placed in granulator and carries out the granulation of 30 mesh of wet process；
(5) by the particle made in drying machine 50 DEG C of dry 15min, cross 40 meshes after dry and carry out whole grain；
(6) auxiliary material maltodextrin powder is added in the particle after whole grain and carries out second batch, then be transported to tablet press machine production tabletting, pressure
Piece machine pressure is controlled in 15-20 Mpa, is packed and stored after the assay was approved.
In the addO-on therapy of momordica grosvenori tablets of the present invention: the effect of Nattokinase: can directly dissolve thrombosed same
When, moreover it is possible to the thrombolysis ability of activation enhancing human body itself, to play the thrombolytic effect of long lasting and stable.Milk powder has qi-restoratives
Damage, beneficial lung stomach, promote the production of body fluid ease constipation the effect of, compound with Siraitia grosvenorii can to Siraitia grosvenorii sugariness height be easy the impairment of the spleen side effect progress
Conditioning.The effect of oatmeal: it reduces blood pressure, reduce cholesterol, prevention and treatment colorectal cancer, prevention and treatment heart disease.The function of soybean lecithin
Effect is: soybean lecithin can inhibit the absorption of enteral cholesterol, therefore can reduce blood cholesterol levels and lipotropic effect, also
It can promote cell Proliferation, it is made to flush, be mainly used for atherosclerosis, acute hepatitis, chronic hepatitis, fatty liver, cirrhosis, mind
Through weak etc..The effect of basil seed: having effects that toxin expelling, heat-clearing, invigorating the spleen, nourishing the stomach and Weight-reducing health, can also improve neutralization sieve
The side effect of Chinese fruit.The effect of soy meal: containing a large amount of unsaturated fatty acid, various trace elements, vitamin and high-quality egg
White matter.Soybean is processed to produce a variety of bean product, is having for the cardiovascular patients such as hypertension, artery sclerosis, heart disease
Beneficial food.
The present invention, not only can be with by the way that certain proportion milk powder, oatmeal, basil seed and soy meal are compounded with Siraitia grosvenorii
Clearing heat and cooling blood, cough-relieving of promoting the production of body fluid, tender skin benefit face, moistening lung for removing phlegm, and the side effect of the Siraitia grosvenorii impairment of the spleen can be improved, at the same time
Nattokinase can effectively reduce the formation of thrombus of heart blood vessel in formula, and the solvable blood lipid of soybean lecithin substantially increases momordica grosvenori tablets
Trophic function, have the advantages that simple process, full of nutrition and natural without side-effects.
Specific embodiment
A kind of momordica grosvenori tablets, by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed, soy meal
It is formed with maltodextrin powder, wherein each component quality proportioning is Siraitia grosvenorii 5.0%-10.0%；Nattokinase 0.01%-0.5%；Milk
Powder 5.0%-20.0%；Oatmeal 5.0%-20.0%；Soybean lecithin 5.0%-15.0%；Basil seed 5.0%-10.0%；Soy meal
5.0%-15.0%；Surplus is maltodextrin powder.
The preparation process of above-mentioned momordica grosvenori tablets is by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, orchid
Fragrant son and soy meal carry out weighing mixing, softening, granulation, dry whole grain, are added auxiliary material maltodextrin powder, last tabletting, specifically
Processing step is as follows:
(1) by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed and soy meal according to product formula
Proportion requirement carries out weighing weighing respectively；
(2) above-mentioned load weighted raw material is placed in mixing agitator and carries out mixing to uniformly for 30min；
(3) it is that be prepared into softwood spare for wetting agent stirring that suitable pure water, which is added, in material after mixing；
(4) softwood of above-mentioned preparation is placed in granulator and carries out the granulation of 30 mesh of wet process；
(5) by the particle made in drying machine 50 DEG C of dry 15min, cross 40 meshes after dry and carry out whole grain；
(6) auxiliary material maltodextrin powder is added in the particle after whole grain and carries out second batch, then be transported to tablet press machine production tabletting, pressure
Piece machine pressure is controlled in 15-20 Mpa, is packed and stored after the assay was approved.
In the addO-on therapy of momordica grosvenori tablets of the present invention: the effect of Nattokinase: can directly dissolve thrombosed same
When, moreover it is possible to the thrombolysis ability of activation enhancing human body itself, to play the thrombolytic effect of long lasting and stable.Milk powder has qi-restoratives
Damage, beneficial lung stomach, promote the production of body fluid ease constipation the effect of, compound with Siraitia grosvenorii can to Siraitia grosvenorii sugariness height be easy the impairment of the spleen side effect progress
Conditioning.The effect of oatmeal: it reduces blood pressure, reduce cholesterol, prevention and treatment colorectal cancer, prevention and treatment heart disease.The function of soybean lecithin
Effect is: soybean lecithin can inhibit the absorption of enteral cholesterol, therefore can reduce blood cholesterol levels and lipotropic effect, also
It can promote cell Proliferation, it is made to flush, be mainly used for atherosclerosis, acute hepatitis, chronic hepatitis, fatty liver, cirrhosis, mind
Through weak etc..The effect of basil seed: having effects that toxin expelling, heat-clearing, invigorating the spleen, nourishing the stomach and Weight-reducing health, can also improve neutralization sieve
The side effect of Chinese fruit.The effect of soy meal: containing a large amount of unsaturated fatty acid, various trace elements, vitamin and high-quality egg
White matter.Soybean is processed to produce a variety of bean product, is having for the cardiovascular patients such as hypertension, artery sclerosis, heart disease
Beneficial food.
Claims (2)
1. a kind of momordica grosvenori tablets, it is characterized in that by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed,
Soy meal and maltodextrin powder composition, wherein each component quality proportioning is Siraitia grosvenorii 5.0%-10.0%；Nattokinase 0.01%-
0.5%；Milk powder 5.0%-20.0%；Oatmeal 5.0%-20.0%；Soybean lecithin 5.0%-15.0%；Basil seed 5.0%-10.0%；
Soy meal 5.0%-15.0%；Surplus is maltodextrin powder.
2. the preparation process of momordica grosvenori tablets described in claim 1, it is characterized in that by Siraitia grosvenorii, Nattokinase, milk powder, oat
Powder, soybean lecithin, basil seed and soy meal carry out weighing mixing, softening, granulation, dry whole grain, auxiliary material maltodextrin are added
Powder, last tabletting, the specific process steps are as follows:
(1) by Siraitia grosvenorii, Nattokinase, milk powder, oatmeal, soybean lecithin, basil seed and soy meal according to product formula
Proportion requirement carries out weighing weighing respectively；
(2) above-mentioned load weighted raw material is placed in mixing agitator and carries out mixing to uniformly for 30min；
(3) it is that be prepared into softwood spare for wetting agent stirring that suitable pure water, which is added, in material after mixing；
(4) softwood of above-mentioned preparation is placed in granulator and carries out the granulation of 30 mesh of wet process；
(5) by the particle made in drying machine 50 DEG C of dry 15min, cross 40 meshes after dry and carry out whole grain；
Auxiliary material maltodextrin powder is added in particle after whole grain and carries out second batch, then is transported to tablet press machine production tabletting, tabletting
Machine pressure is controlled in 15-20 Mpa, is packed and stored after the assay was approved.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811474320.5A CN109259229A (en) | 2018-12-04 | 2018-12-04 | Momordica grosvenori tablets and its preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811474320.5A CN109259229A (en) | 2018-12-04 | 2018-12-04 | Momordica grosvenori tablets and its preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109259229A true CN109259229A (en) | 2019-01-25 |
Family
ID=65186831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811474320.5A Pending CN109259229A (en) | 2018-12-04 | 2018-12-04 | Momordica grosvenori tablets and its preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109259229A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000210053A (en) * | 1999-01-25 | 2000-08-02 | Ryuichiro Endo | Production of momordica grosvenori-honey product |
| US20010046697A1 (en) * | 2000-04-21 | 2001-11-29 | Shinsaku Takaoka | Bacillus natto culture extract |
| CN101933629A (en) * | 2010-07-14 | 2011-01-05 | 何伟平 | Momordica grosvenori low glycemic index nutrition powder and preparation method thereof |
| CN104256407A (en) * | 2014-10-09 | 2015-01-07 | 南京农业大学 | Functional natto chewable tablet and production process thereof |
| CN106360463A (en) * | 2016-08-30 | 2017-02-01 | 湖南华诚生物资源股份有限公司 | Sugar-free, high-fiber and high-protein siraitia grosvenorii convenient food and preparation method thereof |
| CN106798248A (en) * | 2016-12-14 | 2017-06-06 | 张明玉 | A kind of sugar-free fat-reducing basil seed mung bean cake and preparation method thereof |
-
2018
- 2018-12-04 CN CN201811474320.5A patent/CN109259229A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000210053A (en) * | 1999-01-25 | 2000-08-02 | Ryuichiro Endo | Production of momordica grosvenori-honey product |
| US20010046697A1 (en) * | 2000-04-21 | 2001-11-29 | Shinsaku Takaoka | Bacillus natto culture extract |
| CN101933629A (en) * | 2010-07-14 | 2011-01-05 | 何伟平 | Momordica grosvenori low glycemic index nutrition powder and preparation method thereof |
| CN104256407A (en) * | 2014-10-09 | 2015-01-07 | 南京农业大学 | Functional natto chewable tablet and production process thereof |
| CN106360463A (en) * | 2016-08-30 | 2017-02-01 | 湖南华诚生物资源股份有限公司 | Sugar-free, high-fiber and high-protein siraitia grosvenorii convenient food and preparation method thereof |
| CN106798248A (en) * | 2016-12-14 | 2017-06-06 | 张明玉 | A kind of sugar-free fat-reducing basil seed mung bean cake and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101238841B (en) | Pollen fruit milky tea and preparation thereof | |
| CN104256407B (en) | A kind of feature Chewable Tablets and its production technology | |
| CN105054167A (en) | Cereal beverage with flavor of red dates and preparation method of cereal beverage | |
| CN102132874A (en) | Grain nutritional product | |
| CN108813350A (en) | A kind of formula and its preparation process of hypoglycemic, adjuvant treatment diabetes noodles | |
| CN105901503A (en) | A preparing method of nutritious rice flour | |
| CN103109936A (en) | Banana soymilk and processing process thereof | |
| CN109288071A (en) | The selenoprotein and preparation method thereof extracted from Se-rich grain and selenium-rich sarson | |
| CN102919863B (en) | Sika deer liver/heart powder or particle and preparation method and application thereof | |
| US11000048B2 (en) | Method of producing protein-containing powder | |
| CN103976205B (en) | Endocrine fruit jelly of a kind of improvement and preparation method thereof | |
| CN108902732A (en) | A kind of blueness juice noodles and preparation method thereof | |
| CN108651669A (en) | Sea-buckthorn royal jelly freeze-dried powder pressed candy | |
| CN109259229A (en) | Momordica grosvenori tablets and its preparation process | |
| CN106173787A (en) | One seed oyster effervescent tablet | |
| CN105495621A (en) | Health-care food used for protecting liver and stomach and preparation method thereof | |
| JP2004201598A (en) | Fermented product and method for producing the same | |
| KR20190140737A (en) | Vinegar compositions comprising detox-diet material and manufacturing method thereof | |
| CN107455699A (en) | A kind of ion Vc composition containing pawpaw and preparation method thereof | |
| CN100493362C (en) | Papaya seed milk drink and its production process | |
| CN111280452A (en) | Novel natto polypeptide health food | |
| CN100438767C (en) | A method for preparing glutinous maize milk powder | |
| CN104381791B (en) | A kind of instant abalone raspberry particle electuary and preparation method thereof | |
| JPH0453460A (en) | Functional food | |
| CN107624951A (en) | A kind of tea seed active peptide and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190125 |
|
| RJ01 | Rejection of invention patent application after publication |